Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

OncoMed Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Oct 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - OncoMed Pharmaceuticals Inc (OMED-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

01 Nov 2016 Thomson Reuters Stock Report 12 $25.00

ValuEngine Rating and Forecast Report for OMED

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

30 Oct 2016 ValuEngine, Inc. 11 $25.00

Wright Investors Service Comprehensive Report for Oncomed Pharmaceuticals Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

30 Oct 2016 Wright Reports 68 $75.00

ONCOMED PHARMACEUTICALS INC (OMED=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

29 Oct 2016 Pechala's Reports 2 $25.00

Value Graph: ONCOMED PHARMA -- OMED

28 Oct 2016 Ford Investor Services, Inc. 1 $12.00

OncoMed Pharmaceuticals, Inc. (OMED) - Financial Analysis Review

OncoMed Pharmaceuticals, Inc. (OMED) - Financial Analysis Review Summary OncoMed Pharmaceuticals, Inc. (OncoMed) which focuse...

14 Oct 2016 GlobalData 55 $300.00

OMED.OQ - Event Transcript of OncoMed Pharmaceuticals Inc conference call, Sep. 29, 2016 / 1:30PM ET

Edited Event Transcript of OMED.OQ conference call, Sep. 29, 2016 / 1:30PM ET New York, Oct 17, 2016 (Thomson StreetEve...

29 Sep 2016 Thomson Reuters StreetEvents 8 $75.00

OncoMed Pharmaceuticals, Inc. (OMED) - Financial Analysis Review

OncoMed Pharmaceuticals, Inc. (OMED) - Financial Analysis Review Summary OncoMed Pharmaceuticals, Inc. (OncoMed) which focuse...

12 Sep 2016 GlobalData 46 $300.00

OMED.OQ - Event Transcript of OncoMed Pharmaceuticals Inc conference call, Sep. 08, 2016 / 2:55PM ET

Edited Event Transcript of OMED.OQ conference call, Sep. 08, 2016 / 2:55PM ET Boston, Oct 11, 2016 (Thomson StreetEvent...

08 Sep 2016 Thomson Reuters StreetEvents 10 $75.00